Gemcitabine and Doxorubicin in Treating Patients With Recurrent or Progressive Head and Neck Cancer

Clinical trial NCT00509665 · COMPLETED

Trial details

NCT number: NCT00509665
Sponsor: Medical University of South Carolina
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Head and Neck Cancer

Start date: 2005-06-01
Primary completion: 2011-05-01
Enrollment: 18

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.